Publications
Showing records 1 - 20 (of 66)
Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID
Author
Year
Title
Publisher
3591661 Medinger, Michael; Kleinschmidt, Manuela; Mross, Klaus; Wehmeyer, Barbara; Unger, Clemens; Schaefer, Hans-Eckart; Weber, Renate; Azemar, Marc
2010
c-kit (CD117) expression in human tumors and its prognostic value: an immunohistochemical analysis
Pathology Oncology Research
4499903 Medinger, Michael; Passweg, Jakob
2018
What the internist should know about stem cell transplant in the elderly patient
European journal of internal medicine
1193536 Medinger, Michael; Fischer, Natalie; Tzankov, Alexandar
2010
Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies
Journal of Oncology
3591639 Mross, Klaus; Büchert, Martin; Frost, Annette; Medinger, Michael; Stopfer, Peter; Studeny, Matus; Kaiser, Rolf
2014
Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis
BMC cancer
1194037 Theocharides, Alexandre; Passweg, Jakob R.; Medinger, Michael; Looser, Renate; Li, Sai; Hao-Shen, Hui; Buser, Andreas S.; Gratwohl, Alois; Tichelli, André; Skoda, Radek C.
2008
The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders
Haematologica
3591632 Tschan-Plessl, A.; Halter, Jörg; Heim, Dominik; Medinger, Michael; Passweg, Jakob; Gerull, Sabine
2015
Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation
Annals of hematology
3591673 Drevs, J.; Zirrgiebel, U.; Schmidt-Gersbach, C. I. M.; Mross, K.; Medinger, M.; Lee, L.; Pinheiro, J.; Wood, J.; Thomas, A. L.; Unger, C.; Henry, A.; Steward, W. P.; Laurent, D.; Lebwohl, D.; Dugan, M.; Marmé, D.
2005
Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials
Annals of Oncology
3591638 Medinger, Michael; Passweg, Jakob
2014
Role of tumour angiogenesis in haematological malignancies
Swiss medical weekly
3591677 Medinger, Michael; Soltau, Jens; Unger, Clemens; Drevs, Joachim
2004
Rezeptor-tyrosinkinasen: Angriffspunkte für neue tumortherapien
Medizinische Monatsschrift für Pharmazeuten
3591680 Drevs, Joachim; Medinger, Michael; Schmidt-Gersbach, Carmen; Weber, Renate; Unger, Clemens
2003
Receptor tyrosine kinases: the main targets for new anticancer therapy
Current Drug Targets
3591672 Medinger, Michael; Drevs, Joachim
2005
Receptor tyrosine kinases and anticancer therapy
Current Pharmaceutical Design
3591652 Sigle, Joerg-Peter; Medinger, Michael; Stern, Martin; Infanti, Laura; Heim, Dominik; Halter, Joerg; Gratwohl, Alois; Buser, Andreas
2012
Prospective change control analysis of transfer of platelet concentrate production from a specialized stem cell transplantation unit to a blood transfusion center
Journal of Clinical Apheresis
3591670 Drevs, Joachim; Siegert, Patrizia; Medinger, Michael; Mross, Klaus; Strecker, Ralph; Zirrgiebel, Ute; Harder, Jan; Blum, Hubert; Robertson, Jane; Jürgensmeier, Juliane M.; Puchalski, Thomas A.; Young, Helen; Saunders, Owain; Unger, Clemens
2007
Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors
Journal of Clinical Oncology
3591671 Mross, Klaus; Drevs, Joachim; Müller, Marianne; Medinger, Michael; Marmé, Dieter; Hennig, Jürgen; Morgan, Bruno; Lebwohl, David; Masson, Eric; Ho, Yu-Yun; Günther, Clemens; Laurent, Dirk; Unger, Clemens
2005
Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours
European Journal of Cancer
3591668 Unger, Clemens; Häring, Brigitte; Medinger, Michael; Drevs, Joachim; Steinbild, Simone; Kratz, Felix; Mross, Klaus
2007
Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin
Clinical Cancer Research
4499898 Medinger, Michael; Drexler, Beatrice; Lengerke, Claudia; Passweg, Jakob
2018
Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
Frontiers in oncology
4499913 Baumgartner, Annic; Bargetzi, Mario; Bargetzi, Annika; Zueger, Noemi; Medinger, Micheal; Passweg, Jakob; Schanz, Urs; Samaras, Panagiotis; Chalandon, Yves; Pichard, Claude; Limonta, Alessandro; Wannesson, Luciano; Pabst, Thomas; Duchosal, Michel A.; Hess, Urs; Stanga, Zeno; Mueller, Beat; Schuetz, Philipp
2017
Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison
Nutrition
3591631 Medinger, M; Krenger, W; Jakab, A; Halter, J; Buser, A; Bucher, C; Passweg, J; Tzankov, A
2015
Numerical impairment of nestin(+) bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML
Bone marrow transplantation
3591667 Steinbild, Simone; Arends, Jann; Medinger, Michael; Häring, Brigitte; Frost, Annette; Drevs, Joachim; Unger, Clemens; Strecker, Ralph; Hennig, Jürgen; Mross, Klaus
2007
Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II study
Onkologie
3591642 Rueff, Jessica; Medinger, Michael; Heim, Dominik; Passweg, Jakob; Stern, Martin
2014
Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma
Biology of blood and marrow transplantation
Showing records 1 - 20 (of 66)
